BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34466431)

  • 1. Exploring the Demographic Factors and Facilitators to Addiction Abstinence.
    Taghva M; Shiraly R; Moghimi Sarani E
    Galen Med J; 2018; 7():e1074. PubMed ID: 34466431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Stress Response in Persons with Alcohol Addiction in the Context of Abstinence Duration and Disease Severity].
    Tolic I; Soyka M
    Fortschr Neurol Psychiatr; 2018 Jun; 86(6):356-367. PubMed ID: 29954018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations.
    Haber PS; Riordan BC; Winter DT; Barrett L; Saunders J; Hides L; Gullo M; Manning V; Day CA; Bonomo Y; Burns L; Assan R; Curry K; Mooney-Somers J; Demirkol A; Monds L; McDonough M; Baillie AJ; Clark P; Ritter A; Quinn C; Cunningham J; Lintzeris N; Rombouts S; Savic M; Norman A; Reid S; Hutchinson D; Zheng C; Iese Y; Black N; Draper B; Ridley N; Gowing L; Stapinski L; Taye B; Lancaster K; Stjepanović D; Kay-Lambkin F; Jamshidi N; Lubman D; Pastor A; White N; Wilson S; Jaworski AL; Memedovic S; Logge W; Mills K; Seear K; Freeburn B; Lea T; Withall A; Marel C; Boffa J; Roxburgh A; Purcell-Khodr G; Doyle M; Conigrave K; Teesson M; Butler K; Connor J; Morley KC
    Med J Aust; 2021 Oct; 215 Suppl 7():S3-S32. PubMed ID: 34601742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twelve-step and mutual-help programs for addictive disorders.
    Chappel JN; DuPont RL
    Psychiatr Clin North Am; 1999 Jun; 22(2):425-46. PubMed ID: 10385942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Not Two Sides of the Same Coin: A Qualitative Comparative Analysis of Post-Treatment Abstinence and Relapse.
    Pars E; Hirzalla F; VanDerNagel JEL; Dijkstra BAG; Schellekens AFA
    Subst Abuse Rehabil; 2024; 15():9-19. PubMed ID: 38510337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
    Klimas J; Tobin H; Field CA; O'Gorman CS; Glynn LG; Keenan E; Saunders J; Bury G; Dunne C; Cullen W
    Cochrane Database Syst Rev; 2014 Dec; (12):CD009269. PubMed ID: 25470303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological Correlates of Substance Abuse Among In-Facility Clients of De-addiction and Rehabilitation Centres of District Dehradun: A Cross-Sectional Study.
    Zahin N; Roy D; Sinha R; Maheshwari S; Sethi Y; Patel N
    Cureus; 2023 Aug; 15(8):e42826. PubMed ID: 37664384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the maintenance to abstinence (MTA) program in achieving abstinence in opioid users and improving mental health and quality of life.
    Southey MM; Rees T; Rolfe M; Pit S
    Addict Sci Clin Pract; 2019 Feb; 14(1):4. PubMed ID: 30717808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment.
    Dodge R; Sindelar J; Sinha R
    J Subst Abuse Treat; 2005 Mar; 28(2):189-96. PubMed ID: 15780549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can 12-step group participation strengthen and extend the benefits of adolescent addiction treatment? A prospective analysis.
    Kelly JF; Dow SJ; Yeterian JD; Kahler CW
    Drug Alcohol Depend; 2010 Jul; 110(1-2):117-25. PubMed ID: 20338698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study.
    Gossop M; Stewart D; Marsden J
    Addiction; 2008 Jan; 103(1):119-25. PubMed ID: 18028521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of primary medical care on addiction and medical severity in substance abuse treatment programs.
    Friedmann PD; Zhang Z; Hendrickson J; Stein MD; Gerstein DR
    J Gen Intern Med; 2003 Jan; 18(1):1-8. PubMed ID: 12534757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment retention and abstinence of patients with substance use disorders according to addiction severity and psychiatry comorbidity: A six-month follow-up study in an outpatient unit.
    Daigre C; Rodríguez L; Roncero C; Palma-Álvarez RF; Perea-Ortueta M; Sorribes-Puertas M; Martínez-Luna N; Ros-Cucurull E; Ramos-Quiroga JA; Grau-López L
    Addict Behav; 2021 Jun; 117():106832. PubMed ID: 33529849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient Characteristics Predicting Abstinence in Substance Use Disorder Patients With Comorbid Mental Disorders.
    van Hagen LJ; de Waal MM; Christ C; Dekker JJM; Goudriaan AE
    J Dual Diagn; 2019; 15(4):312-323. PubMed ID: 31566115
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxes of evidence in Russian addiction medicine.
    Mendelevich VD; Zalmunin KY
    Int J Risk Saf Med; 2015; 27 Suppl 1():S102-3. PubMed ID: 26639682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity?
    Ekhtiari H; Noroozi A; Farhoudian A; Radfar SR; Hajebi A; Sefatian S; Zare-Bidoky M; Razaghi EM; Mokri A; Rahimi-Movaghar A; Rawson R
    Addiction; 2020 Jul; 115(7):1395-1403. PubMed ID: 31737965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy for Alcohol Dependence: The 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies.
    Rolland B; Paille F; Gillet C; Rigaud A; Moirand R; Dano C; Dematteis M; Mann K; Aubin HJ
    CNS Neurosci Ther; 2016 Jan; 22(1):25-37. PubMed ID: 26768685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.